Currently, we are unable to explain this phenomenon; however, similar to many drugs that target mutant p53 in cancers [30], future investigation into the therapeutic modulation and molecular mechanism of ØTCUFN3 treatment may help resolve this question. Here, TP53 is linked to cancer.